- Home
- LMFA vs PULM Comparison
LMFA vs PULM Comparison
Compare LMFA & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- PULM
- Stock Information
- Founded
- LMFA 2008
- PULM 2003
- Country
- LMFA United States
- PULM United States
- Employees
- LMFA N/A
- PULM N/A
- Industry
- LMFA Finance: Consumer Services
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- PULM Health Care
- Exchange
- LMFA Nasdaq
- PULM Nasdaq
- Market Cap
- LMFA 18.9M
- PULM 18.3M
- IPO Year
- LMFA 2015
- PULM N/A
- Fundamental
- Price
- LMFA $1.35
- PULM N/A
- Analyst Decision
- LMFA Strong Buy
- PULM
- Analyst Count
- LMFA 1
- PULM 0
- Target Price
- LMFA $5.00
- PULM N/A
- AVG Volume (30 Days)
- LMFA 596.1K
- PULM 17.8K
- Earning Date
- LMFA 11-12-2025
- PULM 11-07-2025
- Dividend Yield
- LMFA N/A
- PULM N/A
- EPS Growth
- LMFA N/A
- PULM N/A
- EPS
- LMFA N/A
- PULM N/A
- Revenue
- LMFA $6,755,925.00
- PULM $369,000.00
- Revenue This Year
- LMFA N/A
- PULM N/A
- Revenue Next Year
- LMFA $15.59
- PULM $134.88
- P/E Ratio
- LMFA N/A
- PULM N/A
- Revenue Growth
- LMFA N/A
- PULM N/A
- 52 Week Low
- LMFA $1.02
- PULM $1.96
- 52 Week High
- LMFA $5.14
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- LMFA 48.77
- PULM 47.11
- Support Level
- LMFA $1.11
- PULM $4.45
- Resistance Level
- LMFA $1.19
- PULM $5.50
- Average True Range (ATR)
- LMFA 0.09
- PULM 0.26
- MACD
- LMFA 0.05
- PULM 0.02
- Stochastic Oscillator
- LMFA 61.76
- PULM 38.53
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).